1-4 of 4
George E. Sandusky
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of Nf1-Deficient Mice

Free
Ciersten A. Burks, Steven D. Rhodes, Waylan K. Bessler, Shi Chen, Abbi Smith, Jeffrey R. Gehlhausen, Eric T. Hawley, Li Jiang, Xiaohong Li, Jin Yuan, Qingbo Lu, Max Jacobsen, George E. Sandusky, David R. Jones, D. Wade Clapp, Jaishri O. Blakeley
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12): 2321–2330.
https://doi.org/10.1158/1535-7163.MCT-19-0123
Published: 02 December 2019
View articletitled, Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of Nf1-Deficient Mice
Open the PDF for Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of Nf1-Deficient Mice in another window
Journal Articles

Antitumor Activity and Mechanistic Characterization of APE1/Ref-1 Inhibitors in Bladder Cancer

Free
Melissa L. Fishel, Hanyu Xia, Jack McGeown, David W. McIlwain, May Elbanna, Ariel A. Craft, Hristos Z. Kaimakliotis, George E. Sandusky, Chi Zhang, Roberto Pili, Mark R. Kelley, Travis J. Jerde
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (11): 1947–1960.
https://doi.org/10.1158/1535-7163.MCT-18-1166
Published: 01 November 2019
View articletitled, Antitumor Activity and Mechanistic Characterization of APE1/Ref-1 Inhibitors in Bladder Cancer
Open the PDF for Antitumor Activity and Mechanistic Characterization of APE1/Ref-1 Inhibitors in Bladder Cancer in another window
Includes: Multimedia, Supplementary data
Journal Articles

Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer Therapeutics

Free
Carolyn C. Arpin, Stephen Mac, Yanlin Jiang, Huiwen Cheng, Michelle Grimard, Brent D.G. Page, Malgorzata M. Kamocka, Sina Haftchenary, Han Su, Daniel P. Ball, David A. Rosa, Ping-Shan Lai, Rodolfo F. Gómez-Biagi, Ahmed M. Ali, Rahul Rana, Helmut Hanenberg, Kagan Kerman, Kyle C. McElyea, George E. Sandusky, Patrick T. Gunning, Melissa L. Fishel
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (5): 794–805.
https://doi.org/10.1158/1535-7163.MCT-15-0003
Published: 05 May 2016
View articletitled, Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer Therapeutics
Open the PDF for Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer Therapeutics in another window
Includes: Supplementary data
Journal Articles

Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model

Free
Eva Tonsing-Carter, Barbara J. Bailey, M. Reza Saadatzadeh, Jixin Ding, Haiyan Wang, Anthony L. Sinn, Kacie M. Peterman, Tiaishia K. Spragins, Jayne M. Silver, Alyssa A. Sprouse, Taxiarchis M. Georgiadis, T. Zachary Gunter, Eric C. Long, Robert E. Minto, Christophe C. Marchal, Christopher N. Batuello, Ahmad R. Safa, Helmut Hanenberg, Paul R. Territo, George E. Sandusky, Lindsey D. Mayo, Christine M. Eischen, Harlan E. Shannon, Karen E. Pollok
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12): 2850–2863.
https://doi.org/10.1158/1535-7163.MCT-15-0237
Published: 06 December 2015
View articletitled, Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
Open the PDF for Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model in another window
Includes: Supplementary data